The global importance of heart failure has risen exponentially in recent years. This is partly due to its prevalence, as much as 2% of the total population, and the high cost of therapy and unfavorable prognosis define the need for modern and novel therapies with the aim of extending the life expectancy of the affected while improving quality of life as well. Telemedicine offers exciting perspectives in mitigating this global challenge. CardioMEMS HF, a recent development of Abott Laboratories, is an implantable sensor which enables the physician to take action in the earliest stages of the chain leading to the transition from stable to decompensated heart failure. Research materials for this study have been gathered from online scientific databases—PubMed and Cochrane Library. An array of studies, published in prestigious scientific journals indicate that CardioMEMS HF prolongs the median life expectancy, improves the quality of life and facilitates a more tailored to the needs of the patient pharmacotherapy. CardioMEMS is an effective, safe, and cost-effective method for patients suffering from heart failure regardless of the ejection fraction.
McDonagh, T. A., Metra, M., Adamo, M. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42(36), 2021.
Hessel, F. P. (2021). Overview of the socio-economic consequences of heart failure. Cardiovascular Diagnosis and Therapy, 11(1), 2021.
Chioncel, O., Čelutkienė, J., Bělohlávek, J. et al. Heart failure care in the Central and Eastern Europe and Baltic region: Status, barriers, and routes to improvement. ESC Heart Failure, 11(4), 2024.
Chaldakov, G. N.. , Aloe, L., Tonchev A. B. et al. Neuro-adipose interactions (bioacotme). Implication in cardiometabolic disease. 16(Proc Rom Acad Series B), 2014; 133–141.
Rančić, G., Fiore, M., Pancheva, R. et al. Adipose tissue: The Renaissance marked by four paradigm shifts. Adipobiology, 6, 2014; 48–53.
Greenhalgh, T., A’Court, C., Shaw, S. Understanding heart failure; explaining telehealth – a hermeneutic systematic review. BMC Cardiovascular Disorders, 17(1), 2017.
Pocock, S. J., Ariti, C. A., McMurray, J. J. V. et al. Predicting survival in heart failure: A risk score based on 39 372 patients from 30 studies. European Heart Journal, 34(19), 2013.
Abraham, W. T., Adamson, P. B., Bourge, R. C. et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. Lancet (London, England), 377(9766), 2011; 658–666.
Lindenfeld, J., Zile, M. R., Desai, A. S. et al. Haemodynamic-guided management of heart failure (GUIDE-HF): A randomised controlled trial. The Lancet, 398(10304), 2021.
Brugts, J. J., Radhoe, S. P., Clephas, P. R. D. et al. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): A randomised clinical trial. Lancet (London, England), 401(10394), 2023; 2113–2123
Clephas, P. R. D., Radhoe, S. P., Boersma, E. et al. Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: A meta-analysis of three randomized controlled trials. European Heart Journal, 44(37), 2023.
Lindenfeld, J., Costanzo, M. R., Zile, M. R. et al. Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction. Journal of the American College of Cardiology, 83(6), 2024.
Adamson, P. B., Abraham, W. T., Bourge, R. C. et al. Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction. Circulation: Heart Failure, 7(6), 2014.
Green, C. P., Porter, C. B., Bresnahan, D. R et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure. Journal of the American College of Cardiology, 35(5), 2000; 1245–1255
Abraham, W. T., Adamson, P. B., Costanzo, M. R. et al. Hemodynamic Monitoring in Advanced Heart Failure: Results from the LAPTOP-HF Trial. Journal of Cardiac Failure, 22(11), 2016; 940.
Prieto, L., & Sacristán, J. A. Problems and solutions in calculating quality-adjusted life years (QALYs). Health and Quality of Life Outcomes, 1(1), 2003; 80.
Neumann, P. J., & Kim, D. D. Cost-effectiveness Thresholds Used by Study Authors, 1990-2021. JAMA, 329(15), 2023; 1312.
Azari, S., Mousavi, S. H., Markazi Moghaddam, N. et al. Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System: A Systematic Review. Medical Journal of the Islamic Republic of Iran, 2023
Cowie, M. R., Thokala, P., Ihara, Z. et al. Real‐time pulmonary artery pressure monitoring in heart failure patients: An updated cost‐effectiveness analysis. ESC Heart Failure, 10(5), 2023; 3046–3054.
